Important notification
10.07.2024 To the attention of all stakeholders We inform you that on 9 July 2024, the European Commission published Regulation […]
Press release
28.06.2024 To the attention of interested persons Hydroxyprogesterone caproate medicines to be suspended from the EU market download document …
Press release
28.06.2024 To the attention of interested persons EMA recommends revoking conditional marketing authorisation for Ocaliva download document …
Press release
28.06.2024 To the attention of interested persons EMA recommends non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna download document […]
Press release
26.06.2024 To the attention of interested persons EU actions to tackle shortages of GLP-1 receptor agonists download document …
Important notification
21.06.2024 To the attention of all importers, distributors and users of medical devices The NAMMDR warns all importers and distributors […]
Important notification
21.06.2024 To the attention of all importers, distributors and users of medical devices The NAMMDR warns all importers and distributors […]
Important notification
18.06.2024 To the attention of all Marketing Authorisation Holders / Legal representatives of Marketing Authorisation Holders As of 01.07.2024, temporary […]
Press release
14.06.2024 To the attention of interested persons Review of painkiller metamizole started download document …
Press release
12.06.2024 To the attention of interested persons Recommendations of the Executive Steering Group on Shortages and Safety of Medicinal Products […]